In a previous study, we found that the incidence of FGFR2 translocation in a cohort of Chinese ICC patients was much lower than that in other countries30, and no prognostic utility and gender trends were observed. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.